Health
US based COBRA diagnostic prostate cancer trial reaches recruitment target
SYDNEY, Feb. 9, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce its diagnostic 64Cu SAR-...
2023-02-09 22:03
2162
Hugel Achieved Record-High Revenue and Operating Profit
* Hugel delivered 2022 revenue of KRW281.7bn, operating profit of KRW102.5bn, up 21.5% YoY and 7.2% YoY, respectively * Botulinum toxin's sales soared by 28.9% YoY; European sales in full swing * Hugel aims to obtain marketing approval and launch products in the U.S. within this year SEOUL, ...
2023-02-09 22:00
2338
AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce Platform
Transaction expected to fuel the Company's growth in the U.S. food market NEW YORK, Feb. 9, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and plans to ...
2023-02-09 21:00
2996
Technoderma Medicines Initiates TDM-180935 Atopic Dermatitis Clinical Program with Phase 1 Dose Escalation Trial
SAN DIEGO, Feb. 9, 2023 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has begun dosing healthy volunteer subjects in its Phase 1 clinical trial of topical TDM-180935 ointment. This first clinical trial in ...
2023-02-09 21:00
1552
First Prescription for COSELA® (trilaciclib) Issued in China
- COSELA®, the world's first and only myeloprotection drug, was prescribed in Jilin Cancer Hospital onJanuary 28, 2023 - Simcere delivers drug to patients in 908 days from execution of license agreement to first prescription NANJING, China, Feb. 9, 2023 /PRNewswire/ -- Simcere Pharmaceutical Gr...
2023-02-09 21:00
2717
DNA Data Company, Asa Ren, Raised An Oversubscribed US$8.15M To Build An Indonesia Population DNA Database
JAKARTA, Indonesia, Feb. 9, 2023 /PRNewswire/ -- Asa Ren, a leading DNA data company based inIndonesia, today announced the closing of a new early stage round of fundings ofUS$ 8.15 Million. This oversubscribed round was co-led by Top Harvest Capital (Silicon ValleyUSA), Kejora Capital (Kejora...
2023-02-09 18:27
3301
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea
YONGIN, South Korea, Feb. 8, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that the World Health Organization (WHO) has awarded prequalification to filling and finish plant onFebruary 3 2023, located in Ochang, South...
2023-02-09 09:21
1755
ImmVira Clinical Snapshot: Intratumoral Injected OV (MVR-T3011 IT) Monotherapy Achieved Median PFS of 12.9 Months on Treatment of Melanoma
SHENZHEN, China, Feb. 8, 2023 /PRNewswire/ -- ImmVira's first intratumoral injected OV product MVR-T3011 IT has shown positive efficacy in the course of clinical studies in the U.S. andChina as of January 2023, with which the monotherapy treatment significantly prolonged PFS to a median of 12.9 m...
2023-02-09 08:00
1704
The National Cancer Society of Malaysia (NCSM), MSD and DoctorOnCall Collaborate In Conjunction with World Cancer Day 2023 to Offer Affordable Health Screenings to Members of the Public
KUALA LUMPUR, Malaysia, Feb. 9, 2023 /PRNewswire/ -- In conjunction with World Cancer Day 2023, The National Cancer Society ofMalaysia (Persatuan Kanser Kebangsaan Malaysia) (NCSM), MSD and DoctorOnCall are collaborating to increase public awareness with regard to cancer by offering free basic he...
2023-02-09 08:00
2482
U.S. Centers for Disease Control to extend National Wastewater Surveillance System contract with Biobot Analytics
CAMBRIDGE, Mass., Feb. 9, 2023 /PRNewswire/ -- The U.S. Centers for Disease Control and Prevention (CDC) has extended its partnership with Biobot Analytics through the National Wastewater Surveillance System (NWSS) to bring COVID-19 and mpox (formerly monkeypox) wastewater analysis to communities...
2023-02-09 06:15
2363
The world's oldest living lab rat points the way to rejuvenation
"Sima", a 47 months-old female rat, is being treated with E5, a treatment intended to recreate the circulatory environment of a young mammal; the maximum recorded lifespan for this species is 45.5 months. MOUNTAIN VIEW, Calif., Feb. 9, 2023 /PRNewswire/ -- An experiment led by Dr. Harold Katcher...
2023-02-09 05:00
2149
Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its ...
2023-02-09 04:04
2252
ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Based on ReviR's Comprehensive Approach to RNA-targeted Technologies
SAN FRANCISCO, Feb. 8, 2023 /PRNewswire/ -- ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for cancer and other genetically-defined diseases, and Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing, an...
2023-02-08 22:00
1885
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held onMarch 1, 2023 at 9:00 a.m. Eastern Time * YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines a...
2023-02-08 21:30
3000
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held onMarch 1, 2023 at 9:00 a.m. Eastern Time * YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines a...
2023-02-08 21:30
3110
Armis Scores as a Top Performer in the 2023 Best in KLAS Software & Services Report
Asset Visibility and Security Company Rated a High Scorer, Showcasing Leading Healthcare Prowess SAN FRANCISCO, Feb. 8, 2023 /PRNewswire/ -- Armis, the leading asset visibility and security company, today announced that it has been named a top performer by KLAS Research in the2023 Best in KLAS S...
2023-02-08 21:05
1932
Lunit and Agfa HealthCare bring breast imaging AI solution to Dubai Academic Health Corporation (DAHC) Dubai Hospital
* Dubai Academic Health Corporation (DAHC) Dubai Hospital to modernize its Breast Cancer Diagnostic and Screening program with Agfa HealthCare's RUBEE for AI framework and Lunit INSIGHT MMG algorithm * The Breast AI Analysis Package is Lunit's first application with Agfa HealthCare since form...
2023-02-08 21:05
2030
Waterdrop internally tests a ChatGPT-like application and will apply It into insurance marketing and services
BEIJING, Feb. 8, 2023 /PRNewswire/ -- In a media interview, Huang Mingxing, who heads Waterdrop's AI business, said Waterdrop has internally tested a ChatGPT like application, and will apply it to insurance marketing and services. As an AI-enabled chatbot application developed by Open AI, ChatGPT...
2023-02-08 21:00
2782
Meihua International Medical Technologies Co. Explores Application of ChatGPT Technologies to Develop Online AI Health Consultation Services
YANGZHOU, China, Feb. 8, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the Company will...
2023-02-08 20:30
1474
Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience
SHANGHAI, Feb. 8, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the application of ChatGPT (Chat Generative Pre-trained Transform...
2023-02-08 20:30
1764
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 318 media titles]
2024-06-25 21:00
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15695
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
13476
THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
2024-06-19 11:38
9533
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9442
